ASN Meetings
Am J Clin Nutr (June 24, 2009). doi:10.3945/ajcn.2009.27707
This Article
Right arrow Full Text (Publish Ahead of Print[PDF])
Right arrow All Versions of this Article:
90/2/385    most recent
ajcn.2009.27707v1
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Taneja, S.
Right arrow Articles by Bhan, M. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Taneja, S.
Right arrow Articles by Bhan, M. K.
Agricola
Right arrow Articles by Taneja, S.
Right arrow Articles by Bhan, M. K.
© 2009 American Society for Clinical Nutrition

Effect of zinc supplementation on morbidity and growth in hospital-born, low-birth-weight infants1,2,3

Sunita Taneja, Nita Bhandari, Temsunaro Rongsen-Chandola, Dilip Mahalanabis, Olivier Fontaine and Maharaj Kishan Bhan

1 From the Society for Applied Studies, New Delhi, India (ST, NB, and TR-C); the Society for Applied Studies, Kolkata, India (DM); the Department of Child and Adolescent Health and Development, World Health Organization, Geneva, Switzerland (OF); and the All India Institute of Medical Sciences, New Delhi, India (MKB).

2 Supported by the Kenneth and Linda Pollin Foundation, New York Presbyterian Hospital, and Columbia University, through an award, "The Pollin Prize in Pediatrics Research, 2004" (MKB), and the Department of Child and Adolescent Health and Development, the World Health Organization (Geneva, Switzerland). The World Health Organization also provided dispersible zinc tablets free of cost from Nutriset France.

3 Address correspondence to MK Bhan, Department of Pediatrics, All India Institute of Medical Sciences, New Delhi 110029, India. E-mail: community.research{at}cih.uib.no.

Other Members of the Study Group

ABSTRACT

Background: Low-birth-weight infants may have impaired zinc status but little is known about the effect of zinc supplementation.

Objective: The objective was to investigate the effect of daily zinc supplementation on morbidity and anthropometric status in hospital-born, low-birth-weight infants.

Design: In a double-blind, randomized, placebo-controlled trial, 2052 hospital-born term infants with a birth weight ≤2500 g were randomly assigned to receive zinc or placebo. The zinc group received elemental zinc: 5 mg/d for those infants between ages 2 wk and 6 mo and 10 mg/d for those infants aged >6 mo. All-cause hospitalizations, prevalence of diarrhea, acute lower respiratory tract infections, visits to health care providers, weights, and lengths were ascertained at 3, 6, 9, and 12 mo of age.

Results: The supplement was consumed for >85% of the follow-up period. Mean plasma zinc at 12 mo of age was higher in the zinc group (100.2 µg/dL) than in the control group (73.3 µg/dL) (difference in means: 26.9; 95% CI: 19.6, 34.2). The 24-h and 7-d prevalence of diarrhea and acute lower respiratory tract infections was similar at 3, 6, 9, and 12 mo. Care-seeking for illness was significantly lower in the zinc group (difference in proportions: –5.7; 95% CI: –9.9, –1.4; P < 0.05) at 9 mo. The numbers of hospitalizations, weights, and lengths were all similar at all 4 assessments.

Conclusions: Hospital-born, term, low-birth-weight infants do not seem to benefit substantially from zinc supplementation that meets the Recommended Dietary Allowance for zinc in terms of morbidity or physical growth during infancy in this setting. This trial was registered at www.clinicaltrials.gov as NCT00272142.

Received for publication March 4, 2009. Accepted for publication May 12, 2009.